Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06523738

Left Atrial Volume Changes Who Underwent Cardioversion and Recurrence of AF After RF Ablation in Persistent AF (SAFE-AF)

Sponsor: The Second Affiliated Hospital of Chongqing Medical University

View on ClinicalTrials.gov

Summary

Electrical/pharmacological cardioversion improves structural remodeling of left atrium. We hypothesize that persistent atrial fibrillation (AF) patients with more significant left atrial size reduction after cardioversion have lower AF recurrence rates following radiofrequency ablation. The aim is to evaluate the relationship between changes in left atrial size 3 to 6 months after cardioversion and the recurrence rate of atrial fibrillation following radiofrequency ablation.

Official title: Association of Left Atrial Volume Changes After Cardioversion and Recurrence of Atrial Fibrillation After Radiofrequency Ablation in Patients With Persistent Atrial Fibrillation

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2019-07-01

Completion Date

2025-12-31

Last Updated

2024-07-26

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

1. electrical/pharmacological cardioversion. 2.pulmonary vein isolation

1\. electrical/pharmacological cardioversion. 2. pulmonary vein isolation for persistent atrial fibrillation

Locations (1)

The Second Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China